Skip to content
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Search
Advanced Search
Menu
JCP
PCC
News
CME
About
Authors
Sign In
Subscribe
Clinical Topics
View All
Depression
Neurologic
Anxiety
Schizophrenia
Trauma
Psychopharmacology
Bipolar
Tardive Dyskinesia
OCD
Addiction
View All
Columns
View All
ASCP Corner
Clinical & Practical Psychopharmacology
Rounds General Hospital
Academic Highlights
Banner Alzheimer’s Institute
Focus on Geriatric Psychiatry
Jöerg Czekalla, MD
JCP
Original Research
Association of Subjective Well-Being, Symptoms, and Side Effects With Compliance After 12 Months of Treatment in Schizophrenia
January 15, 2007
Anne Karow
,
Jöerg Czekalla
,
Ralf W. Dittmann
, et al
JCP
Original Research
Prediction of Remission as a Combination of Symptomatic and Functional Remission and Adequate Subjective Well-Being in 2960 Patients With Schizophrenia
November 15, 2006
Martin Lambert
,
Benno G. Schimmelmann
,
Dieter Naber
, et al
JCP
Original Research
Analysis of the QTc Interval During Olanzapine Treatment of Patients With Schizophrenia and Related Psychosis
March 1, 2001
Jöerg Czekalla
,
Charles M. Beasley, Jr.
,
Mary Anne Dellva
, et al
JCP
Article
Cardiac Safety Parameters of Olanzapine: Comparison With Other Atypical and Typical Antipsychotics
February 1, 2001
Jöerg Czekalla
,
Sara Kollack-Walker
,
Charles M. Beasley, Jr.
